[ad_1]
US-listed shares of Aurora Cannabis Inc.
CBA + 3.34%
CBA + 3.15%
fell 9.2% in pre – market trading, ahead of the teleconference of the post – profit cannabis company scheduled for 9 am Eastern Time. The company announced that its fourth-quarter sales last Wednesday were below expectations already lowered. Andrew Carter, an analyst at Stifel Nicolaus, reiterated his portfolio rating, saying he thought the stock would remain under pressure considering the prospects of a capital increase in the coming months. "We believe that Aurora will have to visit the capital markets by the first quarter of year 20 to apply for significant funding from the dynamic growth program," Carter said in a note addressed to to customers. He thinks it will probably weigh on the sentiment of the investors. The stock has lost 16.3% in the last three months, while the ETFMG Alternative Harvest ETF
MJ + 0.86%
fell 20.8% and the S & P 500
SPX, + 0.72%
gained 4.2%.
[ad_2]
Source link